Drug Topics, Digital Edition, September 2009

An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.

Results from the CATALYST trial showed patients who received mifepristone had a mean HbA1c reduction of 1.47%,

Amid the continuously evolving role of pharmacists in today’s health care landscape, independent owners like Amina Abubakar, PharmD, AAHIVP, are advancing the profession through innovation.

Pharmacy technicians must be recognized and empowered as essential, long-term professionals to improve workplace well-being, patient care, and pharmacy success.

Pharmacists are increasingly helping expand access to medication abortion by dispensing mifepristone and providing patient guidance, especially in underserved areas.